Comparison of total body irradiation before and after chemotherapy in pretreatment for hematopoietic stem cell transplantation

Cancer Biother Radiopharm. 2012 Mar;27(2):119-23. doi: 10.1089/cbr.2011.1041. Epub 2011 Dec 8.

Abstract

Objective: To explore the best time to carry out total body irradiation (TBI) in hematopoietic stem cell transplantation (HSCT) pretreatment.

Methods: Retrospective analysis was applied in 88 cases of HSCT using TBI as pretreatment from March 2001 to June 2009 in our hospital. Using 8 MV X-ray, all the patients were irradiated by linear accelerator in 2 consecutive days, with a total dose of 7-11 Gy and an instantaneous dose rate ranging between 4.0 and 5.0 cGy/min. Of the 88 cases, 40 cases were given traditional high-dose chemotherapy before TBI (Group CT/TBI), and 48 cases were given TBI before chemotherapy (Group TBI/CT) instead.

Results: Eighty-seven cases of transplantation were successful, with no serious complications, including radiation pneumonia. Compared with Group CT/TBI, Group TBI/CT showed similar incidence of complications (p=0.08), similar recent chemotherapy toxicity (p=0.833), and significantly lower recent radiation toxicity (p=0.000).

Conclusions: TBI in the pretreatment of HSCT is safe and effective. Using TBI before the high-dose chemotherapy can maintain the same pretreatment effect, effectively reduce apparent immediate reaction/discomfort during TBI, reduce preparation workload of radiotherapy, and lower radiation side-effects. Further research is needed to expand its clinical application.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antilymphocyte Serum / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Cytarabine / administration & dosage
  • Female
  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Leukemia / drug therapy
  • Leukemia / surgery
  • Leukemia / therapy*
  • Lymphoma / drug therapy
  • Lymphoma / surgery
  • Lymphoma / therapy*
  • Male
  • Middle Aged
  • Radiotherapy Dosage
  • Retrospective Studies
  • Transplantation Conditioning / methods*
  • Whole-Body Irradiation / adverse effects
  • Whole-Body Irradiation / methods*
  • Young Adult

Substances

  • Antilymphocyte Serum
  • Cytarabine
  • Cyclophosphamide